Erratum: DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology (Brain (2016) 139 (1680-879) DOI: 10.1093/brain/aww080);DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology

Brain

Volumn 139, Issue 6, 2016, Pages 1680-1687

  Taipa, Ricardo ^a   Pereira, Conceição ^b   Reis, Ines ^a   Alonso, Isabel ^b   Bastos Lima, Antonio ^a   Melo Pires, Manuel ^a   Magalhães, Marina ^a  

^a Institute of Biomedical Sciences Abel Salazar   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

DJ 1; Lewy body; PARK7; Pathology; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; DJ 1 PROTEIN; LEVODOPA; PROTEIN DEGLYCASE DJ-1;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN HISTOLOGY; BRAIN TISSUE; CASE REPORT; CEREBELLUM; CERVICAL DYSTONIA; CONSANGUINEOUS MARRIAGE; DISEASE ASSOCIATION; DYSPHAGIA; FASCIA DENTATA; GENE EXPRESSION; GENE MUTATION; GENERAL CONDITION DETERIORATION; GENERALIZED DYSTONIA; GENETIC ANALYSIS; HAND TREMOR; HUMAN; HUMAN TISSUE; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; IMPOTENCE; IN VITRO STUDY; INVOLUNTARY MOVEMENT; LEWY BODY; LIMITED MOBILITY; LOCUS CERULEUS; MALE; MENTAL DEFICIENCY; MEYNERT BASAL NUCLEUS; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MUSCLE ATROPHY; MUTATIONAL ANALYSIS; MYOTATIC REFLEX; NEURITE; NEUROFIBRILLARY TANGLE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PATHOGENICITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETICULAR FORMATION; SOMNOLENCE; SPEECH DISORDER; SUBSTANTIA NIGRA PARS COMPACTA; THALAMUS INTRALAMINAR NUCLEUS; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; VAGUS NERVE DORSAL NUCLEUS; WALKING DIFFICULTY; BIOSYNTHESIS; BRAIN; COMPLICATION; GENETICS; METABOLISM; MUTATION; NERVE DEGENERATION; PARKINSON DISEASE; PATHOLOGY; SUBSTANTIA NIGRA;

BRAIN; HUMANS; LEWY BODIES; LOCUS COERULEUS; MALE; MIDDLE AGED; MUTATION; NERVE DEGENERATION; PARKINSON DISEASE; PROTEIN DEGLYCASE DJ-1; SUBSTANTIA NIGRA;

EID: 84978829850     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aww234     Document Type: Erratum

References (28)

1. Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol 2003; 54: 283-6.
2. Annesi G, Savettieri G, Pugliese P, D'Amelio M, Tarantino P, Ragonese P, et al. DJ-1 mutations and parkinsonism-dementiaamyotrophic lateral sclerosis complex. Ann Neurol 2005; 58: 803-7.
3. Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 2004; 127: 420-30.
4. Bonifati V, Breedveld GJ, Squitieri F, Vanacore N, Brustenghi P, Harhangi BS, et al. Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset. Ann Neurol 2002; 51: 253-6.
5. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256-9.
6. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389-404.
7. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
8. Brooks D, Halliday GM. Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res Bull 2009; 78: 97-104.
9. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: S21-3.
10. Dickson DW. Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med 2012; 2: a009258.
11. Duda JE, Giasson BI, Mabon ME, Miller DC, Golbe LI, Lee VM, et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 2002; 104: 7-11.
12. Elobeid A, Soininen H, Alafuzoff I. Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 2012; 123: 97-104.
13. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996; 55: 259-72.
14. Galvin JE, Uryu K, Lee VM, Trojanowski JQ. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci USA 1999; 96: 13450-5.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-9.
16. Hague S, Rogaeva E, Hernandez D, Gulick C, Singleton A, Hanson M, et al. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol 2003; 54: 271-4.
17. Moore DJ, Zhang L, Dawson TM, Dawson VL. A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J Neurochem 2003; 87: 1558-67.
18. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-3.
19. Paisan-Ruiz C, Li A, Schneider SA, Holton JL, Johnson R, Kidd D, et al. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging 2012; 33: 814-23.
20. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-7.
21. Quinn N, Critchley P, Marsden CD. Young onset Parkinson's disease. Mov Disord 1987; 2: 73-91.
22. Samaranch L, Lorenzo-Betancor O, Arbelo JM, Ferrer I, Lorenzo E, Irigoyen J, et al. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 2010; 133: 1128-42.
23. Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2004; 2: e362.
24. Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson's disease: progress and therapeutic implications. Mov Disord 2013; 28: 14-23.
25. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839-40.
26. van der Merwe C, Jalali Sefid Dashti Z, Christoffels A, Loos B, Bardien S. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1. Eur J Neurosci 2015; 41: 1113-25.
27. van Duijn CM, Dekker MC, Bonifati V, Galjaard RJ, Houwing-Duistermaat JJ, Snijders PJ, et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 2001; 69: 629-34.
28. Zondler L, Miller-Fleming L, Repici M, Goncalves S, Tenreiro S, Rosado-Ramos R, et al. DJ-1 interactions with alpha-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease. Cell Death Dis 2014; 5: e1350.